Diagnostics in Focus: Enabling Precision from Discovery to Monitoring
Panel discussion summary
This year’s panel explores the evolving role of diagnostics in advancing precision medicine — from discovery to real-world application. We’ll examine how innovations in biomarker development, lab automation and data-driven diagnostics are transforming how we detect, characterize and monitor disease. The discussion will also address technologies enabling minimal residual disease (MRD) detection and recurrence monitoring, while reflecting on the broader convergence of diagnostics, informatics and therapeutic decision-making. With perspectives spanning assay development, clinical integration and enabling platforms, the panel offers a comprehensive view of where diagnostics is heading next.
Date, time and room information
May 6, 13:00-13:45, room Marriott 3+4+5
Moderation
| Name | Position | Institution |
|---|---|---|
| Miro Venturi | President | DIAMANTE Healthcare Consulting |
Panelists
| Name | Position | Institution |
|---|---|---|
| Brian Hashemi | CEO | Novigenix |
| Luca Cicchetti | VP Commercial Executive | Bio-Techne |
| Carlo Maria Messina | VP Medical Affairs | EXACT Sciences |
Swiss Biotech Association & Novigenix
